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BAX Gene Expression in Melanoma Metastases 
To the Editor: 
The bcl-2 protooncogene, ini tially discovered as a resul t of its 
involvem en t in the t(14; 18) chrom osomal tran slocatio n in human 
fo ll icular lympho mas [1] , blocks programmed cell dea th (apopto-
sis), g iv ing the cell s that overexpress this p ro tein a survival 
advan tage over no rmal cell s. H igh levels of /Jcl-2 expression prevent 
cell death from cell ular stresses and cytotoxic chemicals including 
ion.izing ra diation , excess ca lcium influx , and a range of chem o-
therapeutic drugs [2]. Tn a previo us stud y it has been shown by 
imm uno hi stochemi stry that melan ocytes and the majo rity of benign 
and ma lignan t pi gm ent cell les io ns express Bcl-2; thus BcI-2 
imm un o reactivity can no t be used as a differential diagn ostic m arker 
to d iscriminate betwee n the val;ous rypes of pigm en t lesions [3]. 
Recen t stud ies in dicate that bcl-2 1S a m em ber of a family of related 
genes, and an in tracellular partner o f BcI-2, Bax, has been de-
scribed. 
Expression of Bax does no t block apoptosis bu t does appear to 
inhi bit the funct ion of BcI-2 perhaps by fo rming BcI- 2- Bax com-
plexes or by competi ng wi th other B cI-2 targets [4]. Consisten t 
abnormal ities in chrom osom es 1, 2, 6, 7, and 9 have been o bserved 
in p rimary and me tastatic m elan om a [5]; the in abilj ry o f the cells to 
unde rgo apoptos is in respo nse to D N A damage may underlie th e 
survjva l an d growth of neoplastic ce ll s. 
To investigate the correlation between bax gene, which regul ates 
the anti.-apoptotic effects ofBcl-2, and bcl-2 gene expressio n in such 
a tumor, we analyzed 10 m etastases fro m melan o m a by reverse 
transcriptase-polym erase chain reactio n (PCR) . O ne m icrogram of 
total RNA was reverse transcri bed in a fi nal volume of 20 J.LI 
conta ining 20 mM T ris HC I (pH 8.3),50 mM KC l, 2.5 mM MgCl2 , 
100 pmol ran dom exa mer, 50 un.its of MuLV reverse transcrip tase 
(Perkin Elm er Cetus) according to the manufacturer 's guidelines. 
The n, 10 J.L l of cDNA were ampli fied in PC R buffer con taining 50 
pmol each of upstrea m (5' GTGGAGGAGCTCTTCAGGGA 3' 
location 431- 450) and downstream (5' AGGCACCCAGGGT-
GATGCAA 3', location 715-734) bcl-2 primers and 2.5 uni ts ofTaq 
polym erase (Polym ed). T he rem aining 10-J.L1 ali quo t of cDN A was 
amplified with a primer pa Lr specifi c fo r bax (bax upstrea m,S ' 
GGCCCACCAGCTCTGAGCAGA 3', location 35- 55; bax down-
stream,S' GCCACGTGGGCGTCCCAAAGT 3', location 491-
511). Amplificatio n fo r bcl-2 an d bax were perfo rm ed fo r 30 cycl es. 
A cycle proft le consisted of 1 min 30 seconds at 94°C for 
denaturation, 1 m in at 60°C fo r anneaLing, and 3 miJ1 at 72°C for 
extensio n. T he PCR products were size-fiacti onated by agarose gel 
electrophoresis, transfe rred to Hybond-N Inembrane (Am ersham) 
and hybrid ized to the in tern al probes for bcl-2 or bax (bcl-2 probe, 5 ' 
GGTGGGGTCATGTGTGTGGAGAGCGTCAAC 3', location 
491- 520; bax probe,S' TCCGGCACCTTGGTGCACAGGGC-
CTTGAGC 3' , locatio n 363-393). 
Our data demonstrate tbat the ratio bcl-2lbax expression is 
variable: the contem porary expression of bcl-2 and bax was detected 
in six of ten specimens, w hereas three were fo und positive fo r bcl-2 
and negative for b"x expression . O ne sampl e w as fo und negative 
for /Jc l-2 and positi ve fo r bax (F ig 1). Because the ra tio ofB cl- 2 and 
Bax protein s con tro ls the relative susceptibili ty o f cell s to certain 
ki lli ng sti m uli , o ur fi ndings sugges t that lack o f bax exp ression m ay 
playa ro le in the survival of the m etasta tic m elano ma cells and in 
the progress io n of malignan cy. T hus, fur ther research is needed , 
not only to elucidate the real significa nce o f the variable express ion 
of bcl-2lbnx genes ill m elanoma, but also to understand the 
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F igure 1. A utor adiography o[RT-PCR p r oducts o f RNA ext racted 
from 10 m e t a sta ses of melanoma . T he ampli fied samples were blotted 
and hybridized with 32p pro bes specific fo r bcl-2 o r bas genes. A) 
H ybrid izatio n w ith bcl- 2 pro be. L Oll""' "/ (0 3 and 5 to 9, m etastases frOUl 
m elanom a; lau" 4, negative con tro l (reacti on w ithout R NA). B) H ybridiza-
tion w ith bax probe . LOllc 1 (09 the same as in A. 
mechanism s by w hich the leve l of expression o f BcI-2 and Bax may 
be alte red . 
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